• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Masimo CEO: Our Business Is Back on Track

cafead

Administrator
Staff member
  • cafead   May 09, 2024 at 11:12: AM
via Masimo has had a lot of distractions in the past couple years, between its high-profile patent battle against Apple plus tensions between CEO Joe Kiani and the board.

In March, the company revealed plans to separate its controversial consumer business. The same week, Politan nominated two more candidates to Masimo’s board.

article source